Zhihong J Wang MD

Pediatric Hematology & Oncology•Richmond, VA

Pediatric Hematologic Oncology, Pediatric Neuro-Oncology, Pediatric Solid Tumor Oncology

Associate Professor, Pediatrics, Virginia Commonwealth University

Join to View Full Profile

1000 E Broad StRichmond, VA 23219
Phone+1 804-828-9605
Fax+1 804-628-5848

Education & Training

Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 2004 - 2006
Children's Hospital of MichiganResidency, Pediatrics, 2002 - 2004
Henry Ford Health/Henry Ford HospitalInternship, Transitional Year, 2001 - 2002
Stanford Health CarePost-Doctoral Fellowship, 1995 - 1997
Beijing Medical UniversityClass of 1984

Certifications & Licensure

MI State Medical License 2001 - 2026
VA State Medical License 2018 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
ACTIVE_NOT_RECRUITING
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
RECRUITING
Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Start of enrollment: 2011 Sep 01
Terminated
Phase 2
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET) Start of enrollment: 2011 Feb 01
Unknown status
Not Applicable
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Start of enrollment: 2011 Aug 01
Completed
Phase 2
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
COMPLETED
PHASE2
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment Start of enrollment: 2014 Mar 05
Recruiting
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Start of enrollment: 2013 Nov 04
Completed
Phase 3
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
ACTIVE_NOT_RECRUITING
PHASE4
Roles: Contact
Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN Start of enrollment: 2022 Jan 21
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Salvage therapies for first relapse of SHH medulloblastoma in early childhood.
Craig Erker, Martin Mynarek, Marie Simbozel, Brandon T Craig, Virginia L Harrod
Neuro-Oncology. 2025-04-04
Intracranial Germinoma in Two Caucasian American Siblings With Autism Spectrum Disorder.
Stephanie A Toll, Leigh Anne Flore, Hamza S Gorsi, Neena I Marupudi, Swati Mody
Journal of Pediatric Hematology/oncology. 2024-03-01
18 citations
Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas.
Amy E Armstrong, Allan J Belzberg, John R Crawford, Angela C Hirbe, Zhihong J Wang
BMC Cancer. 2023-06-16

Press Mentions

Calcitriol Enhances Doxorubicin-Induced Apoptosis in Papillary Thyroid Carcinoma Cells via Regulating VDR/PTPN2/p-sTAT3 PathwayMay 1st, 2020